Association between catechol-O-methyltrasferase val108/158met genotype and prefrontal hemodynamic response in schizophrenia

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Takizawa, Ryu ^a   Tochigi, Mamoru ^a   Kawakubo, Yuki ^a   Marumo, Kohei ^a   Sasaki, Tsukasa ^b   Fukuda, Masato ^c   Kasai, Kiyoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BIPERIDEN; CATECHOL METHYLTRANSFERASE; CHLORPROMAZINE; DIAZEPAM; METHIONINE; NEUROLEPTIC AGENT; VALINE; OXYHEMOGLOBIN;

ADULT; AGE; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GENDER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INTELLIGENCE QUOTIENT; MALE; NEAR INFRARED SPECTROSCOPY; PREFRONTAL CORTEX; SCHIZOPHRENIA; SYMPTOM; TASK PERFORMANCE; VERBAL COMMUNICATION; AMINO ACID SUBSTITUTION; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; HEMODYNAMICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMODYNAMICS; HUMANS; MALE; METHIONINE; OXYHEMOGLOBINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; SCHIZOPHRENIA; VALINE;

EID: 65549110767     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005495     Document Type: Article

References (67)

1. Sham PC, Jones P, Russell A, Gilvarry K, Bebbington P, et al. (1994) Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study. Br J Psychiatry 165(4): 466-473.
2. Badner JA, Gershon ES (2002) Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7(4): 405-411.
3. Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, et al. (2005) Webb GD, Gatzoulis MA. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A 138(4): 307-313.
4. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, et al. (1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92(17): 7612-7616.
5. Murphy KC, Jones LA, Owen MJ (1999) High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56(10): 940-945.
6. Li T, Ball D, Zhao J, Murray RM, Liu X, et al. (2000) Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry 5(4): 452.
7. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, et al. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98(12): 6917-6922.
8. Munafo MR, Bowes L, Clark TG, Flint J (2005) Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 10(8): 765-770.
9. Williams HJ, Glaser B, Williams NM, Norton N, Zammit S, et al. (2005) No association between schizophrenia and polymorphisms in COMT in two large samples. Am J Psychiatry 162(9): 1736-1738.
10. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, et al. (2002) A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71(6): 1296-1302.
11. Lee SG, Joo Y, Kim B, Chung S, Kim HL, et al. (2005) Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum Genet 116(4): 319-328.
12. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, et al. (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34(13): 4202-4210.
13. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, et al. (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95(17): 9991-9996.
14. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ (2004) Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24(23): 5331-5335.
15. Desimone R (1995) Neuropsychology. Is dopamine a missing link? Nature 376(6541): 549-550.
16. Goldman-Rakic PS, Muly EC 3rd, Williams GV (2000) D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31(2-3): 295-301.
17. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, et al. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100(10): 6186-6191.
18. Woodward ND, Jayathilake K, Meltzer HY (2007) COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Schizophr Res 90(1-3): 86-96.
19. Bertolino A, Caforio G, Blasi G, De Candia M, Latorre V, et al. (2004) Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 161(10): 1798-1805.
20. Weickert TW, Goldberg TE, Mishara A, Apud JA, Kolachana BS, et al. (2004) Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 56(9): 677-682.
21. Suto T, Fukuda M, Ito M, Uehara T, Mikuni M (2004) Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain activation study. Biol Psychiatry 55(5): 501-511.
22. Takizawa R, Kasai K, Kawakubo Y, Marumo K, Kawasaki S, et al. (2008) Reduced frontopolar activation during verbal fluency task in schizophrenia: a multi-channel near-infrared spectroscopy study. Schizophr Res 99(1-3): 250-262.
23. Boas DA, Dale AM, Franceschini MA (2004) Diffuse optical imaging of brain activation: approaches to optimizing image sensitivity, resolution, and accuracy. Neuroimage 23 Suppl 1: S275-288.
24. Hoshi Y (2003) Functional near-infrared optical imaging: utility and limitations in human brain mapping. Psychophysiology 40(4): 511-520.
25. Obrig H, Villringer A (2003) Beyond the visible-imaging the human brain with light. J Cereb Blood Flow Metab 23(1): 1-18.
26. Strangman G, Boas DA, Sutton JP (2002) Non-invasive neuroimaging using near-infrared light. Biol Psychiatry 52(7): 679-693.
27. Hock C, Villringer K, Muller-Spahn F, Wenzel R, Heekeren H, et al. (1997) Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)-correlation with simultaneous rCBF-PET measurements. Brain Res 755(2): 293-303.
28. Kameyama M, Fukuda M, Yamagishi Y, Sato T, Uehara T, et al. (2006) Frontal lobe function in bipolar disorder: a multichannel near-infrared spectroscopy study. Neuroimage 29(1): 172-184.
29. Kuwabara H, Kasai K, Takizawa R, Kawakubo Y, Yamasue H, et al. (2006) Decreased prefrontal activation during letter fluency task in adults with pervasive developmental disorders: a near-infrared spectroscopy study. Behav Brain Res 172(2): 272-277.
30. Matsuo K, Kato T, Taneichi K, Matsumoto A, Ohtani T, et al. (2003) Activation of the prefrontal cortex to trauma-related stimuli measured by near-infrared spectroscopy in posttraumatic stress disorder due to terrorism. Psychophysiology 40(4): 492-500.
31. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9(1): 97-113.
32. First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured Clinical Interview for DSM-IV Axis I disorders. New York, U.S.A.: Biometric Research Department, New York State Psychiatric Institute.
33. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2): 261-276.
34. Hollingshead AB (1965) Two-factor index of social position. New Haven, U.S.A.: Yale University Press.
35. Matsuoka K, Uno M, Kasai K, Koyama K, Kim Y (2006) Estimation of premorbid IQ in individuals with Alzheimer's disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin Neurosci 60(3): 332-339.
36. Yamashita Y, Maki A, Ito Y, Watanabe E, Koizumi H (1996) Noninvasive near-infrared topography of human brain activity using intensity modulation spectroscopy. Opt Eng 35: 1046-1049.
37. Okada E, Delpy DT (2003) Near-infrared light propagation in an adult head model. II. Effect of superficial tissue thickness on the sensitivity of the near-infrared spectroscopy signal. Appl Opt 42(16): 2915-2922.
38. Okamoto M, Dan H, Sakamoto K, Takeo K, Shimizu K, et al. (2004) Three-dimensional probabilistic anatomical cranio-cerebral correlation via the international 10-20 system oriented for transcranial functional brain mapping. Neuroimage 21(1): 99-111.
39. Tsuzuki D, Jurcak V, Singh AK, Okamoto M, Watanabe E, et al. (2007) Virtual spatial registration of stand-alone fNIRS data to MNI space. Neuroimage 34(4): 1506-1518.
40. Strangman G, Culver JP, Thompson JH, Boas DA (2002) A quantitative comparison of simultaneous BOLD fMRI and NIRS recordings during functional brain activation. Neuroimage 17(2): 719-731.
41. Hoshi Y, Kobayashi N, Tamura M (2001) Interpretation of near-infrared spectroscopy signals: a study with a newly developed perfused rat brain model. J Appl Physiol 90(5): 1657-1662.
42. Singh AK, Dan I (2006) Exploring the false discovery rate in multichannel NIRS. Neuroimage 33(2): 542-549.
43. Brahmbhatt SB, Haut K, Csernansky JG, Barch DM (2006) Neural correlates of verbal and nonverbal working memory deficits in individuals with schizophrenia and their high-risk siblings. Schizophr Res 87(1-3): 191-204.
44. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, et al. (2000) Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 10(11): 1078-1092.
45. Cabeza R, Nyberg L (2000) Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci 12(1): 1-47.
46. Elfgren CI, Risberg J (1998) Lateralized frontal blood flow increases during fluency tasks: influence of cognitive strategy. Neuropsychologia 36(6): 505-512.
47. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52(7): 701-707.
48. Ehlis AC, Reif A, Herrmann MJ, Lesch KP, Fallgatter AJ (2007) Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders. Neuropsychopharmacology 32(1): 162-170.
49. Ho BC, Wassink TH, O'Leary DS, Sheffield VC, Andreasen NC (2005) Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 10(3): 229, 287-298.
50. Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, et al. (2002) Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry 59(7): 662-663.
51. Lu BY, Martin KE, Edgar JC, Smith AK, Lewis SF, et al. (2007) Effect of catechol O-methyltransferase val(158)met polymorphism on the p50 gating endophenotype in schizophrenia. Biol Psychiatry 62(7): 822-825.
52. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, et al. (2002) A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159(4): 652-654.
53. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, et al. (2006) Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 11(9): 867-877, 797.
54. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18(7): 2697-2708.
55. Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, et al. (2006) The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129(Pt 2): 399-410.
56. Tunbridge EM, Harrison PJ, Weinberger DR (2006) Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60(2): 141-151.
57. Henry JD, Crawford JR (2004) A meta-analytic review of verbal fluency performance following focal cortical lesions. Neuropsychology 18(2): 284-295.
58. Lee J, Folley BS, Gore J, Park S (2008) Origins of Spatial Working Memory Deficits in Schizophrenia: An Event-Related fMRI and Near-Infrared Spectroscopy Study. PLoS ONE 3(3): e1760.
59. Semendeferi K, Armstrong E, Schleicher A, Zilles K, Van Hoesen GW (2001) Prefrontal cortex in humans and apes: a comparative study of area 10. Am J Phys Anthropol 114(3): 224-241.
60. Ramnani N, Owen AM (2004) Anterior prefrontal cortex: insights into function from anatomy and neuroimaging. Nat Rev Neurosci 5(3): 184-194.
61. Palmatier MA, Kang AM, Kidd KK (1999) Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46(4): 557-567.
62. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, et al. (2001) Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50(11): 825-844.
63. Winterer G, Weinberger DR (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27(11): 683-690.
64. Moore H, West AR, Grace AA (1999) The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 46(1): 40-55.
65. Bertolino A, Caforio G, Blasi G, Rampino A, Nardini M, et al. (2007) COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. Schizophr Res 95(1-3): 253-255.
66. Roffman JL, Weiss AP, Goff DC, Rauch SL, Weinberger DR (2006) Neuroimaging-genetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia. Harv Rev Psychiatry 14(2): 78-91.
67. Meyer-Lindenberg A, Nicodemus KK, Egan MF, Callicott JH, Mattay V, et al. (2008) False positives in imaging genetics. Neuroimage 40(2): 655-661.